Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3340179

CC1(C)CCC(NCc2ccc(-c3cccc(C(=O)NCCc4ccc(-c5ccccc5)cc4)c3)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR5A P47898 4/20 0.45
EPHX2 P34913 1/20 0.44
NR1H4 Q96RI1 1/20 0.44
HDAC1 Q13547 4/20 0.44
SLC2A1 P11166 3/20 0.44
OPRM1 P35372 4/20 0.43
OPRD1 P41143 4/20 0.43
OPRK1 P41145 4/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
PRKD1 Q15139 2/20 0.42
HTR1A P08908 1/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
HTR1D P28221 1/20 0.41
HTR1B P28222 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR7 P34969 1/20 0.41
ADRA1B P35368 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3340242 0.99 HTR5A (0.46) HTR5AEPHX2NR1H4HDAC1SLC2A1
SCHEMBL12651148 0.95 EPHX2 (0.49) HTR5AEPHX2NR1H4HDAC1OPRM1
Trifluoroacetic Acid SCHEMBL3340372 0.94 OPRM1 (0.44) HTR5AEPHX2NR1H4HDAC1SLC2A1
SCHEMBL12651379 0.94 RAB9A (0.49) HTR5AEPHX2NR1H4HDAC1OPRM1
Trifluoroacetic Acid SCHEMBL3341197 0.92 EPHX2 (0.52) HTR5AEPHX2NR1H4HDAC1SLC2A1
SCHEMBL12651252 0.88 F10 (0.48) HTR5AEPHX2NR1H4HDAC1OPRM1
Trifluoroacetic Acid SCHEMBL3340186 0.88 HDAC1 (0.46) HTR5AEPHX2NR1H4HDAC1SLC2A1
SCHEMBL12651503 0.86 EPHX2 (0.58) EPHX2NR1H4HDAC1RAB9APRKD1
Trifluoroacetic Acid SCHEMBL3338278 0.85 OPRM1 (0.50) HTR5AHDAC1SLC2A1OPRM1OPRD1
Trifluoroacetic Acid SCHEMBL3341720 0.84 DPP4 (0.44) HTR5ASLC2A1OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140323487-A1 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors GLAXOSMITHKLINE LLC 2014-10-30 US disclosed
US-20100113512-A1 METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS IGNAR DIANE MICHELE 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113512-A1 METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS OPRL1, OPRD1, OPRK1 HTR5A 281/4885EPHX2 2604/4885NR1H4 190/4885
US-20140323487-A1 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors OPRL1, OPRM1, OPRK1 HTR5A 204/4885EPHX2 1937/4885NR1H4 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.